Approval · Notice of Compliance 5200 · 1995
NIMOTOP: Notice of Compliance 5200
Issued February 27, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5200
- Date
- February 27, 1995
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Adjunct in the management of subarachnoid hemorrhage, calcium channel blocking agent
Products in this notice
Medicinal ingredients
- NIMODIPINE 30 MG per CAP
- NIMODIPINE 0.2 MG per ML